Gilead Decides On Bigger Dance Floor With Tango

Immuno-Oncology Collaboration Expands To Up To 15 Novel Targets

 
• By Joseph Haas

Gilead is making a $20m equity investment in Tango, with the biotech’s series B backers also increasing their investments.

Feet of professional tango dancers in dancing movement on bright background indoors
A discovery deal between Gilead and Tango is turning into a dance marathon

More from Deals

More from Business